30
Participants
Start Date
July 1, 2020
Primary Completion Date
March 1, 2021
Study Completion Date
July 9, 2021
CPI-006
Participants will receive a single dose of CPI-006 at one of four dose levels (0.3 mg/kg, 1.0 mg/kg, 3.0 mg/kg, or 5.0 mg/kg) along with standard of care.
Standard of Care
Participants will receive standard of care treatment only.
Icahn School of Medicine at Mount Sinai, New York
Temple University Hospital, Philadelphia
El Centro Regional Medical Center, El Centro
Lead Sponsor
Corvus Pharmaceuticals, Inc.
INDUSTRY